Results 41 to 50 of about 127,816 (300)

COVID-19: Time for Post-Exposure Prophylaxis? [PDF]

International Journal of Environmental Research and Public Health, 2020
From a healthcare perspective, infection due to the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and the ensuing syndrome called COVID-19 (coronavirus disease 2019) represents the biggest challenge the world has faced in several decades. Particularly worrisome are the high contagiousness of the virus and the saturation
Gentile I., Maraolo A. E., Piscitelli P., Colao A.   +3 more
openaire   +3 more sources

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Exploring Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Knowledge in Incarcerated Men

American Journal of Men's Health, 2022
People who are incarcerated have a disproportionately high risk of contracting human immunodeficiency virus (HIV). While there is no known cure for HIV, there are biomedical approaches that can successfully manage the virus and prevent its transmission ...
Pamela Valera, Zaire S. Ali, Diamond Cunningham, Christopher McLaughlin, Sebastian Acevedo   +4 more
doaj   +1 more source

Towards elimination of dog-mediated human rabies: experiences from implementing a large-scale demonstration project in Southern Tanzania [PDF]

, 2017
No abstract ...
Abela-Ridder, Bernadette, Changalucha, Joel, Cleaveland, Sarah, Hampson, Katie, Jaswant, Gurdeep, Kazwala, Rudovick, Lembo, Tiziana, Lushasi, Kennedy, Makungu, Selemani, Mancy, Rebecca, Maziku, Matthew, Mbunda, Eberhard M., Mchau, Geofrey, Meslin, François-Xavier, Mpolya, Emmanuel Abraham, Mtema, Zacharia, Nanai, Alphoncina, Ngeleja, Chanasa, Rysava, Kristyna, Sambo, Maganga, Sikana, Lwitiko, Townsend, Sunny   +21 more
core   +2 more sources

The Role of Calcitonin Gene‐Related Peptide in High‐Altitude Headache: A Prospective Field Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective High‐altitude headache (HAH) is a common neurological condition associated with rapid ascent to high altitude. The pathophysiological mechanisms underlying HAH remain incompletely understood. Calcitonin gene‐related peptide (CGRP), a neuropeptide implicated in migraine pathophysiology, may play a key role in the pathophysiology of ...
Roman Schniepp, Ludwig Karrasch, Helena Breitenstein, Andreas Straube, Katharina Kamm   +4 more
wiley   +1 more source

Changes in HIV post-exposure prophylaxis prescriptions before and after the introduction of HIV pre-exposure prophylaxis at a sexual health clinic in Melbourne, Australia, 2011–2021

Australian and New Zealand Journal of Public Health
Objective: HIV pre-exposure prophylaxis (PrEP) became available in Victoria, Australia, in 2016. We examined non-occupational post-exposure prophylaxis (nPEP) usage among gay, bisexual and other men who have sex with men (MSM) before and after PrEP ...
Ranjit S. Samra, Christopher K. Fairley, Jason J. Ong, Ei T. Aung, Eric PF. Chow   +4 more
doaj   +1 more source

PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future

Vaccines, 2023
With no expected vaccine for HIV in the near future, we aimed to define the current situation and challenges for pre- and post-exposure prophylaxis (PrEP and PEP) in Central and Eastern Europe (CEE).
Deniz Gokengin, Dominik Bursa, Agata Skrzat-Klapaczynska, Ivailo Alexiev, Elena Arsikj, Tatevik Balayan, Josip Begovac, Alma Cicic, Gordana Dragovic, Arjan Harxhi, Kerstin Aimla, Botond Lakatos, Raimonda Matulionyte, Velida Mulabdic, Cristiana Oprea, Antonios Papadopoulos, Nino Rukhadze, Dalibor Sedlacek, Lubomir Sojak, Janez Tomazic, Anna Vassilenko, Marta Vasylyev, Antonija Verhaz, Nina Yancheva, Oleg Yurin, Justyna Kowalska   +25 more
doaj   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW). [PDF]

, 2016
We conducted a longitudinal and cross-sectional analysis of depressive symptomology in iPrEx, a randomized, placebo-controlled trial of daily, oral FTC/TDF HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men. Depression-
Amico, K Rivet, Avelino-Silva, Vivian I, Burns, David, Chodacki, Piotr, Defechereux, Patricia A, Fernandez, Telmo, Glidden, David V, Grant, Robert M, iPrEx Study Team, Liu, Albert Y, Mayer, Kenneth H, McMahan, Vanessa M, Mehrotra, Megha, Vargas, Lorena   +13 more
core   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source